A Study to Evaluate the Safety and Effect of STC3141 Continuous Infusion in Subjects With Severe Corona Virus Disease 2019（COVID-19）Pneumonia

NCT04880694 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe COVID-19 Pneumonia

Interventions

DRUG: STC3141
DRUG: STC3141

Sponsor

Grand Medical Pty Ltd.

Collaborators

[object Object]